Introduction
Segmenting brain tumors in medical imaging is a complex task due to the high variability in tumor morphology and the deformation of surrounding healthy tissue. Traditional methods typically rely on either top-down generative class models, which are computationally expensive, or bottom-up graph-based methods, which lack semantic understanding. This paper proposes a hybrid approach that integrates Bayesian tissue classification into a multilevel graph-based segmentation framework, specifically the Segmentation by Weighted Aggregation (SWA) algorithm.
Methodology: Model-Aware Affinities
The core contribution is the development of model-aware affinities. Unlike standard graph-based methods that calculate affinities based solely on raw intensity differences, this approach treats tissue class labels (e.g., tumor, edema, brain) as hidden variables. The affinity between two nodes is defined as the probability that they belong to the same tissue class, calculated by summing over all possible class assignments.
This integration allows the algorithm to leverage class-specific knowledge during the aggregation process. In the SWA framework, the image is iteratively coarsened into a pyramid of graphs. While class evidence may be weak at the pixel level, it becomes increasingly robust as nodes are aggregated into larger clusters, allowing for more accurate boundary delineation.
Multi-modal Synergy
The proposed method effectively utilizes multi-modal MRI data (T1, T1 post-contrast, and FLAIR). Different modalities provide distinct cues for different tissue types; for example, FLAIR is essential for identifying edema, while T1 post-contrast is superior for delineating the tumor core. The model-aware affinity calculation incorporates specific weights for each modality depending on the pair of tissue classes being compared.
Results and Discussion
The method was evaluated on 30 glioblastoma multiforme (GBM) studies. The system achieved Jaccard scores of 0.85 ± 0.04 for tumor segmentation and 0.75 ± 0.08 for edema. Qualitatively, the approach demonstrates a superior ability to segment diffuse and complex structures like edema compared to model-blind graph methods.
However, the current model has limitations. The use of simple Gaussian distributions for tissue classes fails to capture the bimodal intensity of necrotic tissue. Furthermore, the modality weights were manually assigned based on expert knowledge. Future research will focus on automatically learning these parameters and incorporating additional features such as texture and shape priors to enhance segmentation accuracy.
Conclusion
By combining the strengths of Bayesian classification and multilevel graph segmentation, this framework provides a powerful tool for the joint segmentation and classification of brain tumors. The use of model-aware affinities ensures that the bottom-up aggregation process is informed by top-down tissue models, leading to more reliable and clinically relevant results.
Summary updated